secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001551306-26-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny expects Q4 2025 revenue, net income, Adj. EBITDA slightly above prior guidance
--------------------------------------------------------------------------------

- CEO cites favorable Q4 member engagement vs. November guidance.
- Expects Q4 revenue, net income and Adjusted EBITDA slightly above prior ranges.
- Update excludes non-cash impacts from departure of President Michael Sturmer.
- Presenting at 44th Annual JP Morgan Healthcare Conference on Jan 13, 2026.
- No specific revised figures provided; guidance remains qualitative.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130626000009/0001551306-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130626000009/pgny-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001551306-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer